Provided by Tiger Trade Technology Pte. Ltd.

PAVmed

10.50
+0.35003.45%
Volume:40.98K
Turnover:425.38K
Market Cap:15.72M
PE:-1.58
High:10.63
Open:9.99
Low:9.75
Close:10.15
52wk High:28.44
52wk Low:6.00
Shares:1.50M
Float Shares:1.20M
Volume Ratio:1.17
T/O Rate:3.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6481
EPS(LYR):99.15
ROE:17.44%
ROA:-36.78%
PB:1.86
PE(LYR):0.11

Loading ...

PAVmed’s Earnings Call: Triumphs and Trials

TIPRANKS
·
Nov 18, 2025

PAVmed Announces Q3 2025 Financial Results and Updates

TIPRANKS
·
Nov 13, 2025

PAVmed reports third quarter 2025 financial results

Reuters
·
Nov 13, 2025

PAVmed Inc - Qtrly Shr Loss $0.29

THOMSON REUTERS
·
Nov 13, 2025

PAVmed Inc. to Report Third Quarter 2025 Financial Results

Reuters
·
Oct 30, 2025

PAVmed Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Oct 21, 2025

Lucid Diagnostics Inc. Files Initial Beneficial Ownership Statement for Director John R. Palumbo

Reuters
·
Oct 08, 2025

PAVmed Subsidiary Veris Health Launches Commercial Phase of Strategic Partnership with Ohio State University Comprehensive Cancer Center

Reuters
·
Oct 07, 2025

PAVmed Subsidiary, Veris Health and the Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

THOMSON REUTERS
·
Oct 07, 2025

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Oct 06, 2025

Press Release: Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

Dow Jones
·
Sep 25, 2025

Press Release: Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

Dow Jones
·
Sep 16, 2025

PAVmed’s Lucid Diagnostics Completes Public Stock Offering

TIPRANKS
·
Sep 11, 2025

Lucid Diagnostics Inc. Files Prospectus Supplement for Common Stock Offering, Raising Approximately $26.9 Million

Reuters
·
Sep 11, 2025

BUZZ-Lucid Diagnostics slides on $25 mln stock sale

Reuters
·
Sep 10, 2025

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
Sep 10, 2025

BRIEF-Lucid Diagnostics Announces Proposed Public Offering Of Common Stock

Reuters
·
Sep 10, 2025

BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology

Reuters
·
Aug 26, 2025

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

THOMSON REUTERS
·
Aug 26, 2025

PAVmed Inc - Executes Non-Binding Letter With Duke University for Technology

THOMSON REUTERS
·
Aug 26, 2025